Medpace Holdings Inc
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medica… Read more
Medpace Holdings Inc (MEDP) - Total Liabilities
Latest total liabilities as of December 2025: $1.52 Billion USD
Based on the latest financial reports, Medpace Holdings Inc (MEDP) has total liabilities worth $1.52 Billion USD as of December 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Medpace Holdings Inc - Total Liabilities Trend (2014–2025)
This chart illustrates how Medpace Holdings Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Medpace Holdings Inc Competitors by Total Liabilities
The table below lists competitors of Medpace Holdings Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Galaxy Entertainment Group Ltd
PINK:GXYEF
|
USA | $14.74 Billion |
|
Boliden AB
ST:BOL
|
Sweden | Skr65.59 Billion |
|
Smith (DS) PLC
PINK:DSSMY
|
USA | $5.30 Billion |
|
Singapore Exchange Limited
PINK:SPXCF
|
USA | $1.87 Billion |
|
Shengyi Technology Co Ltd
SHG:600183
|
China | CN¥14.54 Billion |
|
Zhongjin Gold Corp Ltd
SHG:600489
|
China | CN¥28.68 Billion |
|
YPF S.A. D
BA:YPFD
|
Argentina | AR$17.93 Billion |
|
Luckin Coffee
PINK:LKNCY
|
USA | $14.66 Billion |
Liability Composition Analysis (2014–2025)
This chart breaks down Medpace Holdings Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.74 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 3.30 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.77 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Medpace Holdings Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Medpace Holdings Inc (2014–2025)
The table below shows the annual total liabilities of Medpace Holdings Inc from 2014 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $1.52 Billion | +18.90% |
| 2024-12-31 | $1.28 Billion | +16.16% |
| 2023-12-31 | $1.10 Billion | +13.64% |
| 2022-12-31 | $966.11 Million | +36.65% |
| 2021-12-31 | $707.01 Million | +20.88% |
| 2020-12-31 | $584.90 Million | +40.33% |
| 2019-12-31 | $416.79 Million | +10.19% |
| 2018-12-31 | $378.23 Million | -15.42% |
| 2017-12-31 | $447.19 Million | +21.39% |
| 2016-12-31 | $368.39 Million | -35.43% |
| 2015-12-31 | $570.57 Million | -17.90% |
| 2014-12-31 | $694.94 Million | -- |